queenカジノ

C2H メニュー About C2H Who we are Members Links Access What we do Drug price setting Necessity of evaluation Concept of cost-effecitveness Evaluation of costs Evaluation of outcome Example Other countries (1) Other countries (2) Application in Japan Roles of C2H Results Results (~2019.3) Results (2019.4~) Tools Guideline and others Related literatures PBMs Database Abbreviations Latest news News Events Reports For experts For clinicians/citizens Contact us Japanese search Core to Evidence-Based Health Policy cost-effectiveness evaluation for future healthcare What we do Methods for cost-effectiveness evaluation. Results Results of cost-effectiveness evaluation on medicines and medical devices. Tools Guidelines and tools for implementation of cost-effectiveness evaluation. C2H is the only public research organizationfor official cost-effectiveness evaluation process in Japan C2H (Center for Outcomes Research and Economic Evaluation for Health) is an organization of National Institute of Public Health; it conducts academic analysis of cost-effectiveness evaluation from the scientific viewpoint. This website will dispatch information about cost-effectiveness evaluation in Japan. We are happy if this website contributes to evidence-based health policy (EBHP). more about C2H Tools for cost-effectiveness evaluation Guidelines Related literatures Preference-based measures Database Latest news 202404.28 news New C2H Report: Deucravacitinib (Sotyktu) Report of the cost-effectiveness evaluation on Deucravacitinib (Sotyktu) was released. 202403.13 news New C2H Report: Molnupiravir (Lagevrio) Report of the cost-effectiveness evaluation on Molnupiravir (Lagevrio) was released. 202403.13 news New C2H Report: Finerenone (Kerendia) Report of the cost-effectiveness evaluation on Finerenone (Kerendia) was released. show other news Tweets by C2H Terms of service Privacy policy Coryright © National Institute of Public Health.All Rights Reserved.